WallStreetZenWallStreetZen

NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Glenn WhaleyChief Financial Officer2023-05-155,000$1.75
$8.75kBuy
Joerg NeermannDirector2022-12-1447,000$1.26
$59.03kBuy
Joerg NeermannDirector2022-12-1335,000$1.25
$43.61kBuy
Joerg NeermannDirector2022-11-2318,000$1.39
$25.02kBuy
Daniel VittPresident and CEO2022-11-228,000$1.35
$10.80kBuy
Glenn WhaleyChief Financial Officer2022-11-075,000$1.50
$7.48kBuy

1 of 1

IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter15.99%7,132,277$10.20MInsider
Rtw Investments LP9.63%4,294,459$6.14MInstitution
V. Cooperatieve Ua Lsp4.85%2,162,782$3.09MInsider
Omega Fund Management LLC4.01%1,788,160$2.56MInstitution
Gratus Capital LLC3.76%1,678,793$2.40MInstitution
Vanguard Group Inc3.76%1,676,274$2.40MInstitution
Vincent Ossipow3.08%1,371,494$1.96MInsider
Fund Nv3.08%1,371,494$1.96MInsider
Life Bioventure V. Sarl Global3.08%1,371,494$1.96MInsider
Bvf Inc2.58%1,149,425$1.64MInstitution

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX45.30%34.60%Net Buying
KNTE65.17%34.83%Net BuyingNet Selling
ADAG7.60%0.00%
VERU17.58%46.16%
STTK47.44%29.18%Net Selling

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 45.30% institutional shareholders, 34.60% Immunic insiders, and 20.09% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 15.99% of the company. Muneer A. Satter's Immunic shares are currently valued at $10.48M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.